DACN(Ms,Ns) is a disulfide ADC linker reagent bearing mesylate and nosylate leaving groups, designed to improve conjugation efficiency and controlled payload release in antibody-drug conjugates. Keywords: ADC linker, disulfide linker, cleavable linker, mesylate linker.
Structure of 2411082-25-0
* For research and manufacturing use only. We do not sell to patients.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
DACN (Ms Ns) is an abbreviation representing a class of modified nucleotides utilized in diverse biotechnological contexts. Here are four key applications of DACN (Ms Ns):
Nucleic Acid Amplification: In the realm of nucleic acid amplification, DACNs play a pivotal role in techniques like polymerase chain reactions (PCR), heightening both specificity and yield. Through the integration of these modified nucleotides, the precision of DNA replication is enhanced by reducing mismatches during amplification. Researchers rely on DACNs to uphold heightened fidelity in applications such as cloning, sequencing, and genetic analysis, ensuring the accuracy and integrity of genetic information propagation.
Diagnostic Assays: Within diagnostic assays, DACNs contribute to augmented sensitivity and specificity in the detection of pathogens and genetic markers. By incorporating DACNs into probes and primers, diagnostic tests achieve heightened reliability in identifying infections or genetic irregularities. This application holds particular significance in the realm of early disease detection and personalized medicine, empowering healthcare professionals to deliver tailored and precise medical interventions.
Therapeutic Development: The arena of therapeutic development benefits significantly from the incorporation of DACNs in the design of therapeutic oligonucleotides, like antisense molecules and siRNAs. These modified nucleotides bolster the stability and binding affinity of therapeutic agents, thereby enhancing their efficacy in silencing target genes. This innovative approach shows promise in combating a spectrum of genetic and viral diseases, including cancer and hepatitis, providing renewed hope for patients seeking effective treatment options.
Synthetic Biology: Within the domain of synthetic biology, DACNs serve as key components in the construction of artificial genetic circuits and pathways. These modified nucleotides are integrated into synthetic genes and regulatory elements to finely regulate their expression and interactions. This sophisticated manipulation enables the creation of engineered organisms with tailored characteristics, facilitating advancements in diverse applications ranging from biofuel production to environmental cleanup efforts.
| Catalog | Product Name | CAS | Inquiry |
|---|---|---|---|
| BADC-01787 | DACN(Tos2) | 1797508-57-6 | |
| BADC-01834 | DACN(Tos,Ns) | 1797508-58-7 | |
| BADC-01812 | DACN(Tos,Suc-OH) | 2109751-68-8 | |
| BADC-01838 | DACN(Tos2,6-OH) | 2109751-74-6 | |
| BADC-01768 | DACN(Ms) hydrochloride | 2331322-16-6 | |
| BADC-01844 | DACN(Tos) hydrochloride | 2331322-18-8 | |
| BADC-01818 | DACN(Tos,Suc-NHS) | 2411082-26-1 | |
| BADC-01852 | DACN(Tos,Mal) | 2411082-28-3 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.